東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Molecular and Cellular Characterizat...

Voellinger, Jenna L.

FindBook

Google Book

Amazon

博客來

Molecular and Cellular Characterization of Human Embryonic Stem Cell Derived Hepatocytes.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Molecular and Cellular Characterization of Human Embryonic Stem Cell Derived Hepatocytes./
作者:	Voellinger, Jenna L.
面頁冊數:	218 p.
附註:	Source: Dissertation Abstracts International, Volume: 77-06(E), Section: B.
Contained By:	Dissertation Abstracts International77-06B(E).
標題:	Pharmaceutical sciences. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10000222
ISBN:	9781339407203

Molecular and Cellular Characterization of Human Embryonic Stem Cell Derived Hepatocytes.
Voellinger, Jenna L.

Molecular and Cellular Characterization of Human Embryonic Stem Cell Derived Hepatocytes. - 218 p.

Source: Dissertation Abstracts International, Volume: 77-06(E), Section: B.

Thesis (Ph.D.)--University of Washington, 2015.

Primary human hepatocytes are commonly used to evaluate liver drug metabolism and toxicity. Pluripotent stem cell derived hepatocytes (SCDHs) have the potential to overcome access and function-related limitations associated with primary hepatocytes. However, in order for SCDHs to become routinely used in preclinical drug metabolism and toxicity screening, they must demonstrate reproducible activity of drug metabolism proteins, particularly the oxidative CYP enzymes, and at a level comparable to that of primary human hepatocytes.

ISBN: 9781339407203Subjects--Topical Terms:

3173021
Pharmaceutical sciences.

Molecular and Cellular Characterization of Human Embryonic Stem Cell Derived Hepatocytes.
LDR:03124nmm a2200337 4500 001 2077077
005 20161114130219.5
008 170521s2015 ||||||||||||||||| ||eng d
020 $a 9781339407203
035 $a (MiAaPQ)AAI10000222
035 $a AAI10000222
040 $a MiAaPQ $c MiAaPQ
100 1 $a Voellinger, Jenna L. $3 3192562
245 1 0 $a Molecular and Cellular Characterization of Human Embryonic Stem Cell Derived Hepatocytes.
300 $a 218 p.
500 $a Source: Dissertation Abstracts International, Volume: 77-06(E), Section: B.
500 $a Adviser: Edward J. Kelly.
502 $a Thesis (Ph.D.)--University of Washington, 2015.
520 $a Primary human hepatocytes are commonly used to evaluate liver drug metabolism and toxicity. Pluripotent stem cell derived hepatocytes (SCDHs) have the potential to overcome access and function-related limitations associated with primary hepatocytes. However, in order for SCDHs to become routinely used in preclinical drug metabolism and toxicity screening, they must demonstrate reproducible activity of drug metabolism proteins, particularly the oxidative CYP enzymes, and at a level comparable to that of primary human hepatocytes.
520 $a The work presented in this dissertation explores the potential of SCDHs to be used as an in vitro pre-clinical model for drug metabolism studies. Namely, we focus on further identifying how similar SCDHs are to primary human hepatocytes with regard to drug-metabolizing enzymes. Moreover, we performed genotype profiling on the commonly used human embryonic stem cell lines (hESCs) to further identify their utility in pharmacogenetic screening. In addition, we investigated the miRNA expression profile of SCDHs to identify miRNA candidates that could improve the maturity of SCDHs.
520 $a Our data showed that SCDHs are immature compared to primary human hepatocytes in terms of the expression and activity of drug-metabolizing enzymes, notably the CYP enzymes. We found that SCDHs more closely resemble fetal hepatocytes regarding expression of hepatocyte markers, drug-metabolizing enzymes, transporters, and transcription factors. This translated into minimal CYP activity for only CYPs 1A and 3A when examining metabolite formation. In addition, we show that the miRNA expression profile of SCDHs compared to stem cells, cryopreserved hepatocytes and human liver tissue indicates global changes associated with immaturity in SCDHs. Taken together, our findings provide a more thorough characterization of SCDHs with regards to their use in drug metabolism studies, and provide insight into a possible mechanism to enhance the maturity and functionality of SCDHs. Additional studies are warranted to further evaluate the effect of the miRNAs identified here on the differentiation of hepatocytes.
590 $a School code: 0250.
650 4 $a Pharmaceutical sciences. $3 3173021
650 4 $a Toxicology. $3 556884
650 4 $a Biochemistry. $3 518028
650 4 $a Cellular biology. $3 3172791
650 4 $a Oncology. $3 751006
690 $a 0572
690 $a 0383
690 $a 0487
690 $a 0379
690 $a 0992
710 2 $a University of Washington. $b Pharmaceutics. $3 3192563
773 0 $t Dissertation Abstracts International $g 77-06B(E).
790 $a 0250
791 $a Ph.D.
792 $a 2015
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10000222